The Better Pharmaceuticals and Devices for Children Act was introduced by Senator Jack Reed (D-R.I.) and included as part of a bill to reauthorize the Food and Drug Administration’s user fees.
The bill seeks to achieve several goals:
• Ensure pediatric studies are planned earlier in the drug development process.
• Ensure pediatric studies are completed.
• Increase transparency of completed, pending and declined studies in children.
• Continue the success of the pediatric medical device incentive and pediatric device consortia initiative.
The bill now proceeds to a full Senate vote.
Related Articles on Patient Safety:
CDC Issues Restatement on Single Dose, Single Use Vials
Study: Registry Could Help Evaluate Orthopedic Devices
Survey Shows Patients Tolerant of Potentially Harmful Devices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.